[Successful treatment with rituximab in a refractory Stiff-person syndrome]

Rev Neurol (Paris). 2012 Apr;168(4):375-8. doi: 10.1016/j.neurol.2011.09.008. Epub 2012 Feb 14.
[Article in French]

Abstract

Stiff person syndrome is a rare autoimmune disorder characterized by axial and limb progressive stiffness with surimposed spasms and production of autoantibodies to glutamic acid decarboxylase (GAD). We report a case of a 50-year-old woman who developed a stiff person syndrome resistant to conventional immunosuppressive treatments. Eight months after treatment, indexes of stiffness and spasm frequency improved, while however, the blood and CSF rates of anti-GAD increased. This observation illustrates the complexity of stiff person syndrome immunopathogenesis as well as the relevance of rituximab in this indication.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antirheumatic Agents / therapeutic use
  • Female
  • Humans
  • Immunotherapy
  • Middle Aged
  • Remission Induction
  • Rituximab
  • Salvage Therapy
  • Stiff-Person Syndrome / drug therapy*
  • Treatment Failure
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab